Pages that link to "Q34606818"
Jump to navigation
Jump to search
The following pages link to Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus (Q34606818):
Displaying 50 items.
- Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates (Q21090120) (← links)
- Animal models for Ebola and Marburg virus infections (Q21131118) (← links)
- Current ebola vaccines (Q21534720) (← links)
- Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates (Q21586376) (← links)
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA (Q24289279) (← links)
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe (Q24289281) (← links)
- Emerging targets and novel approaches to Ebola virus prophylaxis and treatment (Q24597625) (← links)
- Ebola haemorrhagic fever (Q24629338) (← links)
- Ebola virus disease and critical illness (Q26250274) (← links)
- Clinical development of Ebola vaccines (Q26775792) (← links)
- Filoviruses: One of These Things is (not) Like the Other (Q26783063) (← links)
- Ebola Virus Disease (The Killer Virus): Another Threat to Humans and Bioterrorism: Brief Review and Recent Updates (Q26798860) (← links)
- Ebola virus vaccines: an overview of current approaches (Q26999232) (← links)
- Ebolavirus glycoprotein structure and mechanism of entry (Q27490991) (← links)
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) (Q28051937) (← links)
- Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain (Q28223031) (← links)
- Neglected filoviruses (Q28383265) (← links)
- Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA (Q28396399) (← links)
- Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species (Q28485505) (← links)
- A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines? (Q29994671) (← links)
- Global research trends of World Health Organization's top eight emerging pathogens (Q30151375) (← links)
- Ebola and Marburg virus vaccines (Q30234637) (← links)
- Molecular mechanisms of Ebola pathogenesis. (Q30243891) (← links)
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus (Q30724121) (← links)
- A characterization of aerosolized Sudan virus infection in African green monkeys, cynomolgus macaques, and rhesus macaques (Q33404642) (← links)
- Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. (Q33619065) (← links)
- Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates (Q33703737) (← links)
- Towards Broad Protection Against Ebolaviruses (Q33745567) (← links)
- Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector. (Q33768646) (← links)
- Ebola Vaccine: How Far are we? (Q33831877) (← links)
- Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic (Q33837161) (← links)
- Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors (Q33936327) (← links)
- A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose (Q33964081) (← links)
- Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus (Q33981963) (← links)
- A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus (Q34000122) (← links)
- A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. (Q34029668) (← links)
- Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma (Q34198856) (← links)
- Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses (Q34459935) (← links)
- Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates (Q34468847) (← links)
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial (Q34488529) (← links)
- First Ebola virus vaccine to protect human beings? (Q34547990) (← links)
- DNA vaccines for biodefense (Q34614260) (← links)
- Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy (Q34632946) (← links)
- Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice (Q34761889) (← links)
- Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies (Q34971349) (← links)
- Filovirus emergence and vaccine development: A perspective for health care practitioners in travel medicine (Q35048254) (← links)
- Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVΔG/EBOVgp). (Q35122795) (← links)
- Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles (Q35202880) (← links)
- The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site (Q35212733) (← links)
- Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses (Q35275167) (← links)